Home
All News
FAD website coming soon!
Kick off meeting of FAD next September 21st, in Liège (Belgium)
Report of the FAD kick off meeting
FAD E-newsletter
Symposium on Cardiovascular Murine Models
The first FAD training session “Proteomics in aneurismal disease: from sampling to analysis”
FAD E-newsletter (February 2009)
FAD Annual Scientific Meeting
Workshop on the biochemical analysis of Collagen type I, III and V, collagens responsible for heritable connective tissue disorders.
FAD E-Newletter July 2009
FAD Leaflet
International Meeting on Aortic Diseases, New insights into an old problem, CHU Liège, FAD, APF
FAD Second training session: “Animal models of AAA. Rational to practice”
2010 FAD Scientific meeting
April 2010 FAD e-newsletter
Arteriosclerosis, Thrombosis and Vascular Biology
June 18th and 19th, 2010: FAD Scientific Meeting in Prague (Czech Republic)
8th International Research Symposium on Marfan Syndrome
International Meeting on Aortic Diseases, New insights into an old problem, CHU Liège, FAD, APF
E newsletter July 2010
DeCode puplication in Nature Genetics: Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm

Supported by





       
The EU web-based database for aortic aneurysm is on line

Monday 9 February 2009

 

The EU web-based database for aortic aneurysm is on line since few days.

This database is divided into four clinical sub databases: cases of large AAA (for phenotype of AAA rupture), small screen-detected AAA followed (for phenotype of AAA growth), AAA with endleak after endographting (phenotype of continuing aneurysm development) and patients with familial TAA or AAA (phenotype of genetic causation). The database of screen-detected AAA will be subclassified concerning cases diagnosed by population-based screening or high risk screening.

The objectives are: • to standardize the european methodologies for contribution to the clinical database and to establish standardized sample bank of plasma, DNA, cells, and tissue, associated with the database, • to give support to clinical investigations in different aspects of aneurismal pathology including biomarkers in the follow-up of aneurysm progression and treatment, correlation to function imaging, and therapeutic trials, • to exchange data and biomaterials between the FAD partners, • to allow progress of the other FAD work package.

 
© Fighting Aneurysmal Disease 2008-2009, all right reserved | Privacy Statement